| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Dept. of Neurophysiology , University of Gottingen, Germany; DFG-Research Center of Molecular Physiology of Brain , Germany
2 Department of Anatomy and Molecular Neurobiology, University of Munster, Germany; DFG-Research Center of Molecular Physiology of Brain , Germany
* To whom correspondence should be addressed. E-mail: wzhang1{at}gwdg.de.
Rett syndrome is a neurodevelopmental disorder caused by mutations in the transcriptional repressor methyl-CpG-binding protein 2 (MeCP2) and represents the leading genetic cause for mental retardation in girls. MeCP2-mutant mice have been generated to study the molecular mechanisms of the disease. It was suggested that an imbalance between excitatory and inhibitory neurotransmission is responsible for the behavioral abnormalities but it remained largely unclear which synaptic components are affected and how cellular impairments relate to the time course of the disease. Here, we report that MeCP2 KO mice present an imbalance between inhibitory and excitatory synaptic transmission in the ventrolateral medulla already at postnatal day 7. Focusing on the inhibitory synaptic transmission we show that GABAergic, but not glycinergic, synaptic transmission is strongly depressed in MECP2 KO mice. These alterations are presumably due to both decreased presynaptic GABA release with reduced levels of the vesicular inhibitory transmitter transporter and reduced levels of postsynaptic GABAA receptor subunits 
2 and 4. Our data indicate that in the MeCP2 -/y mice specific synaptic molecules and signaling pathways are impaired in the brainstem during early postnatal development. These observations mandate the search for more refined diagnostic tools and may provide a rationale for the timing of future therapeutic interventions in Rett patients.
This article has been cited by other articles:
|
|
 |
|
  L. Medrihan, A. Rohlmann, R. Fairless, J. Andrae, M. Döring, M. Missler, W. Zhang, and M. W. Kilimann Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses J. Physiol., November 1, 2009; 587(21): 5095 - 5106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Taneja, M. Ogier, G. Brooks-Harris, D. A. Schmid, D. M. Katz, and S. B. Nelson Pathophysiology of Locus Ceruleus Neurons in a Mouse Model of Rett Syndrome J. Neurosci., September 30, 2009; 29(39): 12187 - 12195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tao, K. Hu, Q. Chang, H. Wu, N. E. Sherman, K. Martinowich, R. J. Klose, C. Schanen, R. Jaenisch, W. Wang, et al. From the Cover: Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function PNAS, March 24, 2009; 106(12): 4882 - 4887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fischer, J. Reuter, F. J. Gerich, B. Hildebrandt, S. Hagele, D. Katschinski, and M. Muller Enhanced Hypoxia Susceptibility in Hippocampal Slices From a Mouse Model of Rett Syndrome J Neurophysiol, February 1, 2009; 101(2): 1016 - 1032. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
